SLC2A1 and non-small cell lung carcinoma: Interestingly, we determined high GLUT1 expression to be associated with poor survival in lung ADC patients (Supplementary Fig. 17), suggesting that GLUT1 expression can be employed as a potential prognostic biomarker in NSCLC patients.